Co-Diagnostics, Inc. announced on November 17, 2026, that its distributor in Peru has placed a new order for the Logix Smart ZDC test as the country experiences a rise in dengue activity. The company is also shipping Logix Smart ZDC tests purchased by a European organization for use in a study in Bolivia.
According to the Pan American Health Organization (PAHO), Peru reported 83,430 dengue cases in 2026 through epidemiological week 42. During that week, reported cases were up 51% compared with the average of the previous four weeks.
The Logix Smart ZDC test is a real-time RT-PCR test using patented Co-Primers technology to detect and differentiate between Zika, dengue, and chikungunya viruses. While the test has held CE-IVD marking since 2019 and is available in the European Union and other markets that accept the marking, it is not available for sale in the United States.
Co-Diagnostics is exhibiting at MEDICA 2026, which is taking place November 16–19 in Düsseldorf, Germany. The company is exhibiting as part of the World Trade Center Utah booth at Stand 16E24-1 in Hall 16.
Dwight Egan, Chief Executive Officer of Co-Diagnostics, stated that new orders in South America reflect the need for a multiplex assay that differentiates Zika, dengue, and chikungunya. Egan added that the company is in Düsseldorf this week to build relationships with international customers and distributors.
In Bolivia, the Logix Smart ZDC tests were purchased by a European organization for a study conducted in collaboration with a prominent laboratory. Co-Diagnostics continues to supply real-time PCR instruments to its Bolivian distributor, having shipped approximately 17 units since the beginning of 2025.
Jonathan Freedman, President and CEO of World Trade Center Utah, stated that international trade shows like MEDICA allow companies to meet customers and partners that can drive growth. He noted that the organization helps businesses like Co-Diagnostics make connections to turn global opportunities into business results.
Co-Diagnostics is also hosting two webinars on November 17, 2026. One webinar is for potential customers of its Vector Smart mosquito surveillance solutions, and the other is through CoSara Diagnostics, a joint venture in India, regarding HPV and cervical cancer screening in recognition of World Cervical Cancer Elimination Day.